Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)
NCT04931849
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
PI and Sponsor decided to not proceed with the trial.
Conditions
Thrombocytopenia
Interventions
DRUG:
Avatrombopag
Sponsor
University of Rochester